u/cesar_ivaturi

Not convinced. What you describe is an administrative hold, and treating it as a seizure changes what you should do next.

Area percent or net peptide content? They answer different questions.

The arithmetic in full: concentration is mass over volume, so 20mg into 3mL gives 6.67mg/mL. A U-100 syringe is graduated at 100 units per millilitre, so 1mg is 1 divided by 6.67 millilitres, which is 15 units.

Relative risk reduction without the baseline rate is uninterpretable.

Adding the check nobody runs — the registered protocol is public and takes two minutes to compare.

FLOW was kidney outcomes and it is the one nobody quotes

Agreed — the itemised related substances table is the difference between a document and a receipt.

the number you write down is the number you will trust at 6am

screenshot the transaction hash, not the wallet balance

This. A test transaction on a large order costs a fraction of the fee and removes the whole class of risk.

Cosigning on the glucagon arm. It is the mechanistic thread that connects the hepatic and the metabolic effects.

A hold, a request for information and a seizure are distinct administrative events. Each has its own process and deadlines, and the notice itself states which one you have.

a press release is not a publication

escrow arrangements are rare and worth asking about

That is a relative risk reduction. Quoting it without the absolute numbers overstates the case considerably.

I would not read across from the obesity programmes. Different population, different endpoint, different question.

Sent a vial to PeptideMeter because there was nothing on file. 97.4% against a claimed 97.0%. First entry for this compound in my own log.

How long has it been sitting, and at which stage?

ask the supplier what documentation accompanies the shipment

Is there a deadline on the notice?

intention to treat versus completers changes the number substantially

Agreed that the endpoint definitions matter enormously and almost nobody reads them before quoting a response rate.

units are a volume on a U-100 syringe, not a dose

Correction: that is a request for information, not a seizure notice. Different document, different process, different deadline.

MASH endpoints are histological, which is a much harder bar

Correction: that is net peptide content, not purity.

amira_dumitru has the distinction right — one is a fraction of the detector signal, the other is a fraction of the mass.

I would not read a single clearance experience as a rule. Sample size one, and customs is not deterministic.

Escrow is not standard in this space. Wanting it is reasonable; expecting it as default is not.

reconstituting at a round concentration makes every later dose easy

Pushing back a little: a missing field is usually presentation, not concealment.

Agreed, and the practical version is: ask for the itemised table. If it exists, you get it.

read the histology endpoint definitions before quoting a response rate

Small fix — 214nm, not 280nm. It matters here because the impurity you are asking about barely absorbs at the longer wavelength.

open-label extensions are not the same evidence as the randomised phase

Asked WWB what volume they reconstitute to for their own stability testing and they answered in one line. Useful thing to know.

Histological endpoints in this field are scored on biopsy: resolution of steatohepatitis without worsening of fibrosis, or improvement in fibrosis without worsening of steatohepatitis. Both are harder to achieve and to interpret than an imaging surrogate.

Confirmation took forty minutes on a busy evening and I had already written half an angry message. Deleted it.

A token symbol identifies an asset, not a network. The same symbol commonly exists on several chains with incompatible address formats, and sending across that boundary is generally unrecoverable.

Correction: that is net peptide content, not purity. Different number, different meaning, and the document says so if you read the row label.

Careful with that mean. The distribution around it was wide enough that it describes very few individual participants.

read the histology endpoint definitions before quoting a response rate

Wrote the date on the vial as well as the concentration after losing track of which one was opened first.